OXB

OXFORD BIOMEDICA PLC ORD 50P

TitleTime
2019 Annual report and Accounts & AGM NotificationFri 22/05/20 | 17:28
Holding(s) in CompanyWed 20/05/20 | 14:34
Holding(s) in CompanyWed 13/05/20 | 18:02
OXB receives approval for first two Oxbox suitesWed 13/05/20 | 07:00
PDMR Dealings / Market Share saleMon 11/05/20 | 16:25
Directors Dealings / Market Share PurchasesWed 06/05/20 | 12:36
Preliminary ResultsWed 06/05/20 | 07:00
Total Voting RightsFri 01/05/20 | 09:05
Compliance with LR 9.2.6ER(1)Tue 28/04/20 | 13:04
Director/PDMR ShareholdingFri 24/04/20 | 11:48
Holding(s) in CompanyThu 23/04/20 | 08:38
Holding(s) in CompanyMon 20/04/20 | 16:49
Notice of Results UpdateThu 16/04/20 | 15:17
Total Voting RightsWed 01/04/20 | 09:31
Director Dealings / Market Share PurchaseWed 25/03/20 | 13:06
Director/PDMR ShareholdingFri 20/03/20 | 09:56
Oxford Biomedica Business UpdateWed 18/03/20 | 07:00
License & Supply Agreement with Juno TherapeuticsWed 18/03/20 | 07:00
Total Voting RightsMon 02/03/20 | 09:22
Director Dealings / Market Share PurchaseWed 26/02/20 | 17:55
Class 2 Transaction AnnouncementMon 03/02/20 | 17:04
Total Voting RightsMon 03/02/20 | 11:56
Director Dealings / Market Share PurchaseMon 03/02/20 | 11:55
Block listing ApplicationWed 22/01/20 | 12:11
Block Listing ReturnTue 07/01/20 | 10:17
Total Voting RightsThu 02/01/20 | 11:41
Director Dealings / Market Share PurchaseThu 19/12/19 | 15:27
Extension of Commercial Supply AgreementThu 19/12/19 | 07:00
Total Voting RightsMon 02/12/19 | 09:31
Director Dealings / Market Share PurchaseWed 27/11/19 | 10:05
Holding(s) in CompanyWed 13/11/19 | 16:41
Total Voting RightsFri 01/11/19 | 09:25
Director Dealings / Market Share PurchaseMon 28/10/19 | 12:30
Holding(s) in CompanyWed 23/10/19 | 07:00
Holding(s) in CompanyWed 23/10/19 | 07:00
Total Voting RightsTue 01/10/19 | 10:18
Director Dealings / Market Share PurchaseWed 25/09/19 | 11:41
Director/PDMR ShareholdingMon 16/09/19 | 11:18
Directors Dealings / Market Share PurchasesMon 16/09/19 | 09:15
Long Term Incentive Plan Option GrantFri 13/09/19 | 14:57
Directors Dealings / Market Share PurchasesFri 13/09/19 | 13:13
Director Dealings / Market Share PurchaseFri 13/09/19 | 10:53
Oxford Biomedica Interim ResultsWed 04/09/19 | 07:00
Total Voting RightsMon 02/09/19 | 09:31
Director Dealings / Market Share PurchaseFri 23/08/19 | 11:06
Notice of Interim ResultsFri 09/08/19 | 12:00
Total Voting RightsThu 01/08/19 | 09:18
Director Dealings / Market Share PurchaseThu 25/07/19 | 14:17
Block listing Interim ReviewMon 01/07/19 | 10:01
Total Voting RightsMon 01/07/19 | 09:32
Repayment of Debt FacilityFri 28/06/19 | 07:00
Director Dealings / Market Share PurchaseWed 26/06/19 | 14:52
Board ChangeTue 25/06/19 | 07:00
Director/PDMR ShareholdingMon 10/06/19 | 14:34
Holding(s) in CompanyThu 06/06/19 | 11:39
Holdings in CompanyWed 05/06/19 | 12:06
Holdings in CompanyTue 04/06/19 | 17:38
Total Voting RightsTue 04/06/19 | 09:59
Holding(s) in CompanyMon 03/06/19 | 18:06
Total Voting RightsMon 03/06/19 | 10:31
Exercise of Subscription Option by Novo HoldingsWed 29/05/19 | 18:19
Result of AGMWed 29/05/19 | 13:06
Strategic Investment by Novo Holdings A/STue 28/05/19 | 07:00
Director Dealings / Market Share PurchaseThu 23/05/19 | 18:04
Long Term Incentive Plan Option GrantThu 02/05/19 | 14:53
REPLACEMENT: Total Voting RightsWed 01/05/19 | 12:52
Holdings in CompanyTue 30/04/19 | 17:38
Axovant doses second cohort of AXO-Lenti-PDTue 30/04/19 | 13:15
Director Dealings / Market Share PurchaseThu 25/04/19 | 15:38
Deferred Bonus Plan and LTIP Option GrantsTue 23/04/19 | 13:47
Director Dealings / Market Share TransactionsTue 23/04/19 | 11:38
Exercise of warrantsThu 18/04/19 | 17:33
Annual Report and Accounts & AGM NotificationThu 18/04/19 | 07:00
Total Voting RightsMon 01/04/19 | 11:40
Director Dealings / Market Share PurchaseTue 26/03/19 | 12:57
Japanese approval of Kymriah® (tisagenlecleucel)Tue 26/03/19 | 08:25
Preliminary ResultsThu 14/03/19 | 07:00
Axovant's update on Phase 2 trial of AXO-Lenti-PDMon 11/03/19 | 10:38
Total Voting RightsFri 01/03/19 | 09:30
Director Dealings / Market Share PurchaseMon 25/02/19 | 12:23
Notice of ResultsFri 08/02/19 | 07:00
Director/PDMR ShareholdingThu 07/02/19 | 11:49
Update on programmes outlicensed to SanofiThu 07/02/19 | 09:22
Director Dealings / Market Share TransactionsWed 06/02/19 | 11:00
Director Dealings / Market Share PurchaseTue 05/02/19 | 10:22
Total Voting RightsFri 01/02/19 | 10:00
Director Dealings / Market Share PurchaseThu 24/01/19 | 11:20
Director Dealings / Market Share PurchaseFri 18/01/19 | 10:51
Block listing Interim ReviewThu 03/01/19 | 12:20
Total Voting RightsWed 02/01/19 | 10:17
Director Dealings / Market Share PurchaseFri 21/12/18 | 13:16
Total Voting RightsMon 03/12/18 | 09:53
Longer term Kymriah efficacy and safety dataMon 03/12/18 | 07:00
Director DealingsFri 23/11/18 | 10:41
Oxford Biomedica form digital framework initiativeFri 23/11/18 | 07:00
Block listing applicationFri 09/11/18 | 07:00
Total Voting RightsThu 01/11/18 | 14:41
Axovant Doses First Patient with AXO-Lenti-PDThu 25/10/18 | 07:00
Director Dealings / Market Share PurchaseMon 22/10/18 | 16:39
Details of alliance with Orchard TherapeuticsFri 05/10/18 | 07:00
Total Voting RightsMon 01/10/18 | 09:41
Director/PDMR ShareholdingMon 24/09/18 | 12:20
Oxford BioMedica further capacity expansionThu 13/09/18 | 07:00
Oxford BioMedica Interim ResultsThu 13/09/18 | 07:00
Total Voting RightsMon 03/09/18 | 09:18
Kymriah® receives European Commission ApprovalTue 28/08/18 | 07:00
Director/PDMR ShareholdingWed 22/08/18 | 11:58
RNS notice of results OXBWed 15/08/18 | 07:00
Director/PDMR ShareholdingMon 13/08/18 | 10:55
Director/PDMR ShareholdingMon 13/08/18 | 10:48
PDMR Dealings / Market Share SaleFri 10/08/18 | 11:39
Director Dealings / Market Share Sale and PurchaseFri 10/08/18 | 11:36
Share Options and LTIPs GrantedWed 08/08/18 | 14:45
Partnership for Cystic Fibrosis Gene TherapyMon 06/08/18 | 07:02
Total Voting RightsWed 01/08/18 | 09:53
Director Dealings / Market Share PurchaseMon 23/07/18 | 12:54
Directorate ChangeMon 02/07/18 | 10:25
Total Voting RightsMon 02/07/18 | 09:47
Kymriah receives positive CHMP opinionFri 29/06/18 | 13:37
Holdings in CompanyMon 25/06/18 | 17:19
Confirmation of change of AuditorFri 22/06/18 | 12:05
Director Dealings / Market Share PurchaseFri 22/06/18 | 12:03
Holdings in CompanyThu 21/06/18 | 17:52
OXB and Axovant Sciences Licence AgreementWed 06/06/18 | 07:00
Directorate ChangeMon 04/06/18 | 18:08
Block Listing ReturnFri 01/06/18 | 09:24
Total Voting RightsFri 01/06/18 | 09:19
Holdings in CompanyWed 30/05/18 | 16:23
Result of General MeetingTue 29/05/18 | 13:21
Result of AGMTue 29/05/18 | 13:21
Director Dealings / Market Share PurchaseWed 23/05/18 | 13:40
Proposed Share Capital ConsolidationFri 04/05/18 | 07:00
Kymriah receives FDA approval for DLBCLWed 02/05/18 | 07:00
Total Voting RightsTue 01/05/18 | 09:37
Holding(s) in CompanyThu 26/04/18 | 15:33
2017 Annual Report and Accounts & AGM NotificationThu 26/04/18 | 07:30
Director Dealings / Market Share PurchaseMon 23/04/18 | 11:46
Director Dealings / Market Share PurchaseWed 11/04/18 | 14:11
Director/PDMR ShareholdingMon 09/04/18 | 17:39
Director/PDMR ShareholdingMon 09/04/18 | 10:47
Director/PDMR ShareholdingThu 05/04/18 | 12:08
Total Voting RightsTue 03/04/18 | 09:45
Director/PDMR ShareholdingThu 22/03/18 | 11:05
Board ChangeThu 15/03/18 | 07:01
Preliminary ResultsThu 15/03/18 | 07:01
Result of PlacingFri 09/03/18 | 18:41
PROPOSED PLACING TO RAISE APPROXIMATELY £20.5MFri 09/03/18 | 15:42
Total Voting RightsThu 01/03/18 | 09:33
Director/PDMR ShareholdingFri 23/02/18 | 14:03
Holdings in CompanyTue 20/02/18 | 14:12
Bioverativ Collaboration and Licence AgreementThu 15/02/18 | 07:00
Total Voting RightsThu 01/02/18 | 11:28
£3 million Innovate UK grantTue 23/01/18 | 09:45
Director Dealings / Market Share PurchaseTue 23/01/18 | 09:30
Kymriah receives Priority Review for adult DLBCLWed 17/01/18 | 07:00
BLOCK LISTING RETURNTue 09/01/18 | 09:54
Holding(s) in CompanyWed 03/01/18 | 13:33
Total Voting RightsTue 02/01/18 | 09:49
Director Dealings / Market Share PurchaseWed 20/12/17 | 11:22
Primary analysis results from JULIET trialMon 11/12/17 | 07:08
Total Voting RightsFri 01/12/17 | 10:16
Director Dealings / Market Share PurchaseThu 23/11/17 | 11:29
Holdings in CompanyMon 06/11/17 | 12:06
CTL019 MAA submission to the EMAMon 06/11/17 | 07:37
Total Voting RightsWed 01/11/17 | 09:19
Kymriah submitted to FDA for adults with r/r DLBCLTue 31/10/17 | 16:01
Director Dealings / Market Share PurchaseMon 23/10/17 | 11:27
Total Voting RightsMon 02/10/17 | 11:21
Director Dealings / Market Share PurchaseTue 26/09/17 | 14:55
Long Term Incentive Plan Option GrantTue 26/09/17 | 09:37
Block listing applicationMon 25/09/17 | 15:05
Director DealingsFri 22/09/17 | 12:36
Holding(s) in CompanyWed 20/09/17 | 15:25
Director DealingsTue 19/09/17 | 08:58
Director/PDMR ShareholdingFri 15/09/17 | 09:21
Holdings in CompanyThu 07/09/17 | 10:11
Director/PDMR ShareholdingTue 05/09/17 | 11:45
Director/PDMR ShareholdingTue 05/09/17 | 11:39
Total Voting RightsFri 01/09/17 | 09:25
CTL019 receives FDA approvalWed 30/08/17 | 16:34
Stuart Paynter starts as new CFOTue 29/08/17 | 07:00
Director Dealings / Market Share PurchaseWed 23/08/17 | 10:31
Director Dealings / Market Share Sale and PurchaseTue 22/08/17 | 10:35
Interim ResultsThu 17/08/17 | 07:00
Holding(s) in CompanyMon 07/08/17 | 09:05
Total Voting RightsTue 01/08/17 | 09:19
Notice of Interim ResultsTue 25/07/17 | 07:00
Director Dealings / Market Share PurchaseMon 24/07/17 | 10:10
Director Dealings / Market Share Sale and PurchaseTue 18/07/17 | 08:47
Director DealingsMon 17/07/17 | 12:31
Director/PDMR ShareholdingFri 14/07/17 | 16:49
PDMR ShareholdingFri 14/07/17 | 15:30
LTIP for Long Term Incentive PlanFri 14/07/17 | 11:41
Director Dealings / Market Share Sale and PurchaseThu 13/07/17 | 12:38
Holdings in CompanyThu 13/07/17 | 07:15
FDA AdCom Recommends CTL019 for ApprovalThu 13/07/17 | 07:00
Director Dealings / Market Share Sale and PurchaseTue 11/07/17 | 09:29
Holding(s) in CompanyThu 06/07/17 | 07:15
Major Commercial and Clinical Supply AgreementThu 06/07/17 | 07:00
Total Voting RightsMon 03/07/17 | 14:20
Block ListingMon 03/07/17 | 14:18
Refinancing of Debt FacilityFri 30/06/17 | 10:38
Director Dealings / Market Share PurchaseFri 23/06/17 | 10:12